MARKER THERAPEUTICS, INC. Financing Interest Expense
MARKER THERAPEUTICS, INC. (MRKR) reported Financing Interest Expense of $35.27 thousand for the 3-month period ending 2014-03-31, per its 10-Q/A filed 2014-05-21.
Discontinued › Expense Statement › Interest Expense
us-gaap:FinancingInterestExpense · last filed 2014-05-21
- MARKER THERAPEUTICS, INC. financing interest expense for the quarter ending 2014-03-31 was $35.27K, a 89.47% decline year-over-year.
- MARKER THERAPEUTICS, INC. financing interest expense for the quarter ending 2013-03-31 was $334.89K.
| Period end | Financing Interest Expense 3 month | Financing Interest Expense 173 month |
|---|---|---|
| 2014-03-31 | $35.27K 10-Q/A · filed 2014-05-21 | |
| 2013-12-31 | $7.26M 10-Q/A · filed 2014-05-21 | |
| 2013-03-31 | $334.89K 10-Q/A · filed 2014-05-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |